GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ORIC Pharmaceuticals Inc (STU:4TZ) » Definitions » FCF Yield %

ORIC Pharmaceuticals (STU:4TZ) FCF Yield % : -33.60 (As of Apr. 19, 2025)


View and export this data going back to 2020. Start your Free Trial

What is ORIC Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, ORIC Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-105.41 Mil, and Market Cap is €297.31 Mil. Therefore, ORIC Pharmaceuticals's FCF Yield % for today is -33.60%.

The historical rank and industry rank for ORIC Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:4TZ' s FCF Yield % Range Over the Past 10 Years
Min: -33.6   Med: 0   Max: 0
Current: -33.6


STU:4TZ's FCF Yield % is ranked worse than
66.29% of 1498 companies
in the Biotechnology industry
Industry Median: -15.565 vs STU:4TZ: -33.60

ORIC Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


ORIC Pharmaceuticals FCF Yield % Historical Data

The historical data trend for ORIC Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ORIC Pharmaceuticals FCF Yield % Chart

ORIC Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial -3.26 -10.28 -32.33 -17.75 -19.75

ORIC Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.96 -13.49 -21.93 -16.31 -19.62

Competitive Comparison of ORIC Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, ORIC Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ORIC Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ORIC Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where ORIC Pharmaceuticals's FCF Yield % falls into.


;
;

ORIC Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

ORIC Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-108.727 / 550.4205
=-19.75%

ORIC Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-27.001 * 4 / 550.4205
=-19.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ORIC Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


ORIC Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of ORIC Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ORIC Pharmaceuticals Business Description

Traded in Other Exchanges
Address
240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

ORIC Pharmaceuticals Headlines

No Headlines